ImmunityBio, Inc.IBRXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P100
Near historical high
vs 2Y Ago
5.1x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202522.44%
2024-0.20%
20234.41%
2022-34.97%
2021-77.62%
2020-10.87%
2019-104.48%
20188.51%
2017-85.14%
2016-63.92%